Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID-19 infection: A case report with detailed laboratory data

Makoto Kondo; Yoshiaki Matsushima; Shohei Iida; Ai Umaoka; Takehisa Nakanishi; Koji Habe; Keiichi Yamanaka

doi:10.1002/ccr3.4700

Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID-19 infection: A case report with detailed laboratory data

Clin Case Rep. 2021 Aug 24;9(8):e04700. doi: 10.1002/ccr3.4700. eCollection 2021 Aug.

Authors

Makoto Kondo¹, Yoshiaki Matsushima¹, Shohei Iida¹, Ai Umaoka¹, Takehisa Nakanishi¹, Koji Habe¹, Keiichi Yamanaka¹

Affiliation

¹ Department of Dermatology Graduate School of Medicine Mie University Tsu Japan.

Abstract

The administration of glucocorticoid and hydroxychloroquine (HCQ) may be able to control systemic lupus erythematosus (SLE) activities under COVID-19 infection by suppress the cytokine storm.

Keywords: COVID‐19; hydroxychloroquine; laboratory data; steroid; systemic lupus erythematosus.

Publication types

Case Reports